BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3100625)

  • 1. Target cell recognition structures in LDCC and ODCC.
    Gorman KC; Kane KP; Clark WR
    J Immunol; 1987 Feb; 138(4):1014-9. PubMed ID: 3100625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis.
    Berke G; McVey E; Hu V; Clark WR
    J Immunol; 1981 Aug; 127(2):782-7. PubMed ID: 6265557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective binding of concanavalin A to target cell major histocompatibility antigens is required to induce nonspecific conjugation and lysis by cytolytic T lymphocytes in lectin-dependent cytotoxicity.
    Keren Z; Berke G
    Cell Immunol; 1984 Dec; 89(2):458-77. PubMed ID: 6334564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common role for target cell histocompatibility antigens in both nonspecific and specific T lymphocyte-mediated cytolysis.
    Berke G; Hu V; McVey E; Clark W
    J Cell Biochem; 1982; 18(3):337-49. PubMed ID: 6175653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte-mediated cytolysis. I. A common mechanism for target recognition in specific and lectin-dependent cytolysis.
    Berke G; Hu V; McVey E; Clark WR
    J Immunol; 1981 Aug; 127(2):776-81. PubMed ID: 6972974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells.
    Gromkowski SH; Heagy W; Sanchez-Madrid F; Springer TA; Martz E
    J Immunol; 1983 Jun; 130(6):2546-51. PubMed ID: 6406593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion.
    Kaufmann Y; Berke G
    J Immunol; 1983 Jul; 131(1):50-6. PubMed ID: 6190926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cytotoxic T lymphocyte activity by concanavalin A.
    Sitkovsky MV; Pasternack MS; Eisen HN
    J Immunol; 1982 Oct; 129(4):1372-6. PubMed ID: 6980931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of periodate-oxidized target cells and cytolytic T lymphocytes: a model system of "polyclonal MHC recognition".
    Keren Z; Berke G
    Eur J Immunol; 1986 Sep; 16(9):1049-56. PubMed ID: 3019706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A glycopeptide extract can inhibit cytotoxic T lymphocyte-target cell conjugation in an H-2-restricted manner.
    Pimlott NJ; Miller RG
    J Immunol; 1984 Oct; 133(4):1763-8. PubMed ID: 6236257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte-mediated cytolysis. III. Delineation of mechanisms whereby mitogenic and non-mitogenic lectins mediate lymphocyte-target interaction.
    Berke G; Rosen D; Moscovitch M
    Immunology; 1983 Aug; 49(4):585-92. PubMed ID: 6603417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells can recognize different forms of class I MHC.
    Su RC; Kung SK; Gariépy J; Barber BH; Miller RG
    J Immunol; 1998 Jul; 161(2):755-66. PubMed ID: 9670952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.